Apigenin has been proven to sensitize hepatocellular carcinoma through downregulating the levels of autophagy-related 7 (ATG7) and nuclear factor erythroid 2-related factor 2 (NFE2L2, also known as NRF2) [33,152]. Here, NFE2L2 is linked to hepatocellular carcinoma.